New pill aims to tame high uric acid in kidney patients
NCT ID NCT06310967
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called IG3018 for people with high uric acid, some of whom also have chronic kidney disease. About 60 adults will receive either the drug or a placebo for 4 weeks. Researchers will check safety, side effects, and how well the drug lowers uric acid levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- IG3018 (oral tablet)
- What this could lead to
- If it works, this could point toward a new treatment option for people with high uric acid, especially those with kidney disease.
- What could go wrong
- This is an early-phase trial with only 60 participants, so it is too small to prove effectiveness. The drug may not lower uric acid enough or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chang Gung Memorial Hospital
RECRUITINGTaoyuan, Taiwan, 333423, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chung Shan Medical University Hospital
RECRUITINGTaichung, Taiwan, 402306, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Emeritus Research Pty Ltd -Melbourne
RECRUITINGCamberwell, Victoria, 3124, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Emeritus Research Pty Ltd -Sydney
RECRUITINGBotany, New South Wales, 2019, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Pendlebury Research Pty Ltd T/A Novatrials
RECRUITINGKotara, New South Wales, 2289, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Taipei Medical University Hospital
RECRUITINGTaipei, Taiwan, 110301, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a drug that boosts red blood cells help anemia in kidney disease?
- Predicting kidney trouble in older adults: a data-driven approach to clearer lab results
- Could delaying kidney implant during heart transplant reduce complications?
- Can a new tablet formulation improve how a kidney disease drug is absorbed?
- New drug aims to reduce kidney damage in chronic disease
- Contrast dye Double-Dose: new study tracks kidney fallout in ICU patients